Teva Pharmaceuticals USA, Inc: Granix (tbo-filgrastim) Injection 300 mcg/0.5
Recall reason: Failed Stability Specifications - 12-month stability test result for one of the known peptides is below the specification limit. Recalled by Teva Pharmaceuticals USA, Inc. Distribution: Product was distributed nationwide.. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot # (a) 135738, (b) 137149, (c) 137148, Exp. date 09/30/2025. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report